Stockscreener 앱 받기
8.36
2.45%
-0.21
시간 외 거래:
8.39
0.03
+0.36%
전일 마감가:
$8.57
열려 있는:
$8.61
하루 거래량:
1.90M
Relative Volume:
0.31
시가총액:
$486.04M
수익:
$11.13M
순이익/손실:
$-114.59M
주가수익비율:
-3.6144
EPS:
-2.313
순현금흐름:
$-113.96M
1주 성능:
-7.73%
1개월 성능:
+0.84%
6개월 성능:
-72.04%
1년 성능:
+28.22%
1일 변동 폭
$8.30
$8.67
1주일 범위
$8.27
$9.48
52주 변동 폭
$2.96
$40.37
Capricor Therapeutics Inc Stock (CAPR) Company Profile
명칭
Capricor Therapeutics Inc
전화
(310) 358-3200
주소
10865 ROAD TO THE CURE, SAN DIEGO, CA
Compare CAPR vs VRTX, REGN, MRNA, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CAPR
Capricor Therapeutics Inc
|
8.36 | 486.04M | 11.13M | -114.59M | -113.96M | -2.313 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Capricor Therapeutics Inc Stock (CAPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-30 | 개시 | Alliance Global Partners | Buy |
| 2025-06-26 | 개시 | B. Riley Securities | Buy |
| 2025-05-20 | 개시 | Roth Capital | Buy |
| 2024-10-21 | 개시 | Piper Sandler | Overweight |
| 2024-05-17 | 개시 | Oppenheimer | Outperform |
| 2024-01-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-10-26 | 개시 | Ladenburg Thalmann | Buy |
| 2018-12-26 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2018-01-26 | 재확인 | H.C. Wainwright | Buy |
| 2017-09-15 | 재확인 | H.C. Wainwright | Buy |
| 2017-02-13 | 재개 | Rodman & Renshaw | Buy |
| 2016-07-06 | 재개 | H.C. Wainwright | Buy |
| 2016-06-15 | 개시 | ROTH Capital | Buy |
모두보기
Capricor Therapeutics Inc 주식(CAPR)의 최신 뉴스
CAPR 2-DAY DEADLINE ALERT: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28, 2026 Deadline - GlobeNewswire Inc.
(CAPR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026 - The Globe and Mail
Securities Fraud Class Action Filed Against Capricor Therapeutics, Inc. (CAPR)Levi & Korsinsky Reminds Investors of September 28, 2026 - accessnewswire.com
Levi & Korsinsky Notifies Capricor Therapeutics, Inc. (CAPR) InvestorsLead Plaintiff Deadline on September 28, 2026 - accessnewswire.com
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Capricor Therapeutics, Inc. (CAPR) Investors of September 28, 2026 Deadline - ACCESS Newswire
CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
CAPRICOR DEADLINE SEPTEMBER 28th: Bragar Eagel & Squire, - GlobeNewswire
CAPR Stock On Track For Worst Week Ever After Regulatory Setback For DMD Therapy - Stocktwits
Did You Lose Money on Capricor Therapeutics, Inc. (CAPR)? Levi & Korsinsky Urges Investors to Act Before September 28, 2026 - ACCESS Newswire
Shareholders of Capricor Therapeutics, Inc. (CAPR): Protect Your Rights Before September 28, 2026Contact Levi & Korsinsky - ACCESS Newswire
Kaplan Fox Announces a Securities Class Action Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)Lead Plaintiff Deadline is September 28, 2026 - The Globe and Mail
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesCAPR - PR Newswire
September 28, 2026 Deadline Approaching: Join Class Action Against Capricor Therapeutics, Inc. (CAPR)Contact Levi & Korsinsky - accessnewswire.com
CAPR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
CAPR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - natlawreview.com
CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar
Capricor Therapeutics Shareholder Alert: ClaimsFiler - GlobeNewswire
Kaplan Fox Continues to Remind Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors of the Lead Plaintiff Deadline on September 28, 2026 - The Globe and Mail
SueWallSt Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026CAPR - PR Newswire
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Capricor Therapeutics, Inc. (CAPR) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before September 28, 2026 - ACCESS Newswire
Levi & Korsinsky Urges Capricor Therapeutics, Inc. (CAPR) Shareholders to Act Before Lead Plaintiff Deadline September 28, 2026 - ACCESS Newswire
Lost Money on Capricor Therapeutics, Inc. (CAPR)? Urged to Join Class Action Before September 28, 2026Contact Levi & Korsinsky - ACCESS Newswire
Capricor Therapeutics, Inc. (CAPR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on September 28, 2026 Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) - Barchart.com
CAPRICOR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class ActionCAPR - TMX Newsfile
Securities Lawsuit Alert: Capricor Therapeutics, Inc. (CAPR) InvestorsContact Levi & Korsinsky Before September 28, 2026 - accessnewswire.com
CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics Securities LawsuitContact Levi & Korsinsky - PR Newswire
CAPR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 - TMX Newsfile
Capricor Therapeutics (CAPR) Stock Gets Fair Value Boost After Deramiocel Analyst Revisions - Yahoo Finance
Capricor Therapeutics, Inc. (CAPR) LawsuitInvestors Urged to Contact Levi & Korsinsky Before September 28, 2026 - ACCESS Newswire
Capricor Therapeutics, Inc. Notice of September 28, 2026 - GlobeNewswire
Kaplan Fox Continues to Alert Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Class Action Deadline on September 28, 2026 - NewMediaWire
CAPRICOR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR - FinancialContent
Portnoy Law Firm Announces Class Action on Behalf of Capricor Therapeutics, Inc. Investors - lincolnjournal.com
CAPR LAWSUIT ALERT: Levi & Korsinsky Notifies Capricor Therapeutics, Inc. InvestorsLead Plaintiff Deadline September 28, 2026 - ACCESS Newswire
CAPRICOR THERAPEUTICS, INC. (CAPR) SHAREHOLDER ALERT - GlobeNewswire
Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026 - NewMediaWire
CAPR Class Action: Capricor Therapeutics Investors are Notified of the Upcoming September 28 Deadline in Ongoing Securities Fraud Class Action over Clinical Data - PR Newswire
Capricor Therapeutics, Inc. (CAPR) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of September 28, 2026 Deadline - ACCESS Newswire
Class Action Filed Against Capricor Therapeutics, Inc. (CAPR) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Class Action Alert: Levi & Korsinsky Reminds Capricor Therapeutics, Inc. (CAPR) Investors of September 28, 2026 Deadline - ACCESS Newswire
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - ACCESS Newswire
1 WEEK CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
Bragar Eagel & Squire, P.C. Urges Capricor Therapeutics, Inc. Investors With Large Losses to Contact the Firm Before the September 28th Deadline - The Daily Tribune News
Deadline Alert: Capricor Therapeutics, Inc. (CAPR) - GlobeNewswire
Why Capricor Therapeutics, Inc. (NASDAQ:CAPR) Is In Focus Now? - Kalkine Media
Securities Lawsuit Alert: Capricor Therapeutics, Inc. (CAPR)Contact Levi & Korsinsky Before September 28, 2026 - ACCESS Newswire
Capricor Therapeutics Inc (CAPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.06%
2.55%
자본화:
|
볼륨(24시간):